Nektar Therapeutics (NKTR)
1.27
+0.01
(+0.79%)
USD |
NASDAQ |
May 31, 16:00
1.34
+0.07
(+5.51%)
After-Hours: 20:00
Nektar Therapeutics Accounts Payable (Quarterly): 8.757M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.757M |
December 31, 2023 | 9.848M |
September 30, 2023 | 3.288M |
June 30, 2023 | 2.619M |
March 31, 2023 | 3.696M |
December 31, 2022 | 12.98M |
September 30, 2022 | 5.329M |
June 30, 2022 | 12.35M |
March 31, 2022 | 12.62M |
December 31, 2021 | 9.747M |
September 30, 2021 | 23.66M |
June 30, 2021 | 19.70M |
March 31, 2021 | 22.43M |
December 31, 2020 | 22.14M |
September 30, 2020 | 15.48M |
June 30, 2020 | 19.25M |
March 31, 2020 | 21.79M |
December 31, 2019 | 19.23M |
September 30, 2019 | 21.96M |
June 30, 2019 | 9.346M |
March 31, 2019 | 11.01M |
December 31, 2018 | 5.854M |
September 30, 2018 | 7.494M |
June 30, 2018 | 10.67M |
March 31, 2018 | 11.38M |
Date | Value |
---|---|
December 31, 2017 | 4.782M |
September 30, 2017 | 8.563M |
June 30, 2017 | 6.241M |
March 31, 2017 | 6.951M |
December 31, 2016 | 2.816M |
September 30, 2016 | 7.118M |
June 30, 2016 | 2.328M |
March 31, 2016 | 2.349M |
December 31, 2015 | 2.363M |
September 30, 2015 | 2.279M |
June 30, 2015 | 2.833M |
March 31, 2015 | 5.024M |
December 31, 2014 | 2.703M |
September 30, 2014 | 5.428M |
June 30, 2014 | 7.437M |
March 31, 2014 | 3.064M |
December 31, 2013 | 9.115M |
September 30, 2013 | 3.723M |
June 30, 2013 | 5.572M |
March 31, 2013 | 4.218M |
December 31, 2012 | 2.863M |
September 30, 2012 | 2.624M |
June 30, 2012 | 3.118M |
March 31, 2012 | 1.761M |
December 31, 2011 | 3.019M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.619M
Minimum
Jun 2023
23.66M
Maximum
Sep 2021
13.81M
Average
12.80M
Median
Accounts Payable (Quarterly) Benchmarks
Cara Therapeutics Inc | 4.978M |
Stereotaxis Inc | 3.307M |
Vanda Pharmaceuticals Inc | 4.342M |
Avid Bioservices Inc | 19.51M |
Rigel Pharmaceuticals Inc | 9.276M |